Calendar Gedeon Richter LUXEMBOURG S.E.

Stocks

CHWGR

US3684672054

Pharmaceuticals

End-of-day quote LUXEMBOURG S.E. 11/11/2026			5-day change	1st Jan Change
39.40 ^USD	-1.01%		-1.50%	+30.46%

11-10	Gedeon Richter PLC Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
10-14	Gedeon Richter Plc. Receives Fda Submission Acceptance of New Drug Application for Fylrevy® in the U.S	CI

Chart calendar Gedeon Richter

4595e0ebc2de37a363871b730f00653e.f07j0gD5Ptn73vAQyJIiMRaS41yN02PvKqe_OhPhwiA.ECzSnmK_Zuq3prFWnvtgAWym0Gj95zvadZLqZUaX-hQOGbmfS5pRu4K4wA~0ce9678c8dd332a5b5bff72ad522151a

Upcoming events on Gedeon Richter

No events available

Past events on Gedeon Richter

10/11/2026	Earnings release - Q3 2026
10/11/2026	Earnings presentation
07/08/2026	Earnings presentation
07/08/2026	Earnings release - Q2 2026
12/05/2026	Earnings release - Q1 2026
12/05/2026	Earnings presentation
30/04/2026	Earnings release - Annual 2025
29/04/2026	Annual General Meeting	12:00
27/02/2026	Earnings presentation
27/02/2026	Earnings release - Q4 2025

Past dividends on Gedeon Richter

03/06/2026

Ex-dividend date - 655.4545 HUF

08:00

Annual results

Fiscal Period	December	2023	2024	2025	2026	2027	2028
Net sales Million HUF	Released Forecast Spread	805 158 794 543 1.34%	857 545 863 347 -0.67%	928 962 918 408 1.15%	1 008 000	1 020 834	1 093 689
EBITDA Million HUF	Released Forecast Spread	240 625 231 623 3.89%	310 678 313 329 -0.85%	353 314 339 117 4.19%	374 000	396 366	425 015
EBIT Million HUF	Released Forecast Spread	189 817 185 393 2.39%	261 157 261 168 -0%	292 851 282 057 3.83%	310 000	332 887	359 032
Earnings before Tax (EBT) Million HUF	Released Forecast Spread	171 540 166 767 2.86%	281 077 274 838 2.27%	284 747 272 206 4.61%	301 548	344 742	373 809
Net income Million HUF	Released Forecast Spread	158 850 152 440 4.21%	239 244 234 893 1.85%	232 335 233 067 -0.31%	269 000	290 549	314 929
EPS HUF	Released Forecast Spread	860 851 1%	1 307 1 270 2.91%	1 271 1 242 2.31%	1 359	1 589	1 718
Announcement Date		29/02/24	07/04/25	27/02/26	-

Quarterly results

Fiscal Period	June	2024 Q4	2025 Q1	2025 Q2	2025 S1	2025 Q3	2026 Q1	2026 Q2	2026 Q3
Net sales Million HUF	Released Forecast Spread	221 122 224 994 -1.72%	224 024 220 100 1.78%	241 485 243 800 -0.95%	465 509 467 800 -0.49%	214 692 234 650 -8.51%	220 202 235 533 -6.51%	241 394 237 600 1.6%	234 282 239 550 -2.2%
EBITDA Million HUF	Released Forecast Spread	84 161 74 300 13.27%	81 811 80 200 2.01%	87 612 83 500 4.92%	169 423 165 300 2.49%	79 384 89 100 -10.9%	83 469 87 867 -5%	90 342 84 600 6.79%	88 314 92 200 -4.21%
EBIT Million HUF	Released Forecast Spread	70 958 67 636 4.91%	67 758 66 800 1.43%	72 626 69 300 4.8%	140 384 137 100 2.4%	64 147 74 550 -13.95%	67 367 71 733 -6.09%	76 117 68 500 11.12%	73 298 74 700 -1.88%
Earnings before Tax (EBT) Million HUF	Released Forecast Spread	78 556 70 000 12.22%	81 980 80 100 2.35%
Net income Million HUF	Released Forecast Spread	63 969 55 700 14.85%	68 141 68 100 0.06%			43 347 65 200 -33.52%	65 283 71 300 -8.44%	38 265 44 000 -13.03%	71 399 69 850 2.22%
Announcement Date		07/04/25	13/05/25	06/08/25	06/08/25	06/11/25	12/05/26	07/08/26	10/11/26

Upcoming sector events for Gedeon Richter

Today	KRKA, D. D.	Earnings release - Q3 2026	11:15
Today	CAPLIN POINT LABORATORIES LIMITED	Earnings release - Q2 2027
Today	CAPLIN POINT LABORATORIES LIMITED	Earnings presentation	15:00
14/11/2026	CORONA REMEDIES LIMITED	Earnings release - Q2 2027
14/11/2026	BLISS GVS PHARMA LIMITED	Extraordinary General Meeting
16/11/2026	GLENMARK PHARMACEUTICALS LIMITED	Présentation aux Actionnaires / Analystes
16/11/2026	APICHOPE PHARMACEUTICAL GROUP CO., LTD.	Extraordinary General Meeting	10:30
16/11/2026	CORONA REMEDIES LIMITED	Présentation aux Actionnaires / Analystes	09:30
17/11/2026	GLENMARK PHARMACEUTICALS LIMITED	Présentation aux Actionnaires / Analystes
18/11/2026	GLENMARK PHARMACEUTICALS LIMITED	Présentation aux Actionnaires / Analystes

Past sector events for Gedeon Richter

Today	KRKA, D. D.	Earnings presentation
Today	CAPLIN POINT LABORATORIES LIMITED	Board of Directors Meeting
06/11/2026	GLENMARK PHARMACEUTICALS LIMITED	Earnings presentation	07:00
06/11/2026	CORONA REMEDIES LIMITED	Présentation aux Actionnaires / Analystes	09:00
05/11/2026	GLENMARK PHARMACEUTICALS LIMITED	Earnings release - Q2 2027
05/11/2026	GLENMARK PHARMACEUTICALS LIMITED	Board of Directors Meeting
05/11/2026	CORONA REMEDIES LIMITED	Présentation aux Actionnaires / Analystes	09:00
05/11/2026	SANOFI INDIA LIMITED	Ex-dividend date - 75 INR	09:00
05/11/2026	SMS PHARMACEUTICALS LIMITED	Earnings presentation	10:30
04/11/2026	ZYDUS LIFESCIENCES LIMITED	Earnings release - Q2 2027

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Gedeon Richter

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - Gedeon Richter

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Gedeon Richter